U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07339930) titled 'Phenotyping of Patients With Polycystic Ovary Syndrome' on Jan. 05.
Brief Summary: Polycystic ovary syndrome (PCOS) is the leading endocrine disorder of the reproductive system, affecting 10 to 13% of women of childbearing age. However, there is a significant delay in diagnosis, which may be due to considerable clinical heterogeneity and a lack of information among the general population. The diagnosis is made when two of the three Rotterdam criteria established in 2003 and revised in 2023 are met, namely: 1) menstrual cycle disorders (oligoanovulation) - 2) clinical or biological hyperandrogenism - 3) OPK morphological appearance o...